185 related articles for article (PubMed ID: 23497833)
1. An exploratory dimensional approach to premenstrual manifestation of obsessive-compulsive disorder symptoms: a multicentre study.
Moreira L; Bins H; Toressan R; Ferro C; Harttmann T; Petribú K; Juruena MF; do Rosário MC; Ferrão YA
J Psychosom Res; 2013 Apr; 74(4):313-9. PubMed ID: 23497833
[TBL] [Abstract][Full Text] [Related]
2. The suicidality continuum in a large sample of obsessive-compulsive disorder (OCD) patients.
Velloso P; Piccinato C; Ferrão Y; Aliende Perin E; Cesar R; Fontenelle L; Hounie AG; do Rosário MC
Eur Psychiatry; 2016 Oct; 38():1-7. PubMed ID: 27606439
[TBL] [Abstract][Full Text] [Related]
3. Effects of selective serotonin reuptake inhibitors on thought-action fusion, metacognitions, and thought suppression in obsessive-compulsive disorder.
Besiroglu L; Çetinkaya N; Selvi Y; Atli A
Compr Psychiatry; 2011; 52(5):556-61. PubMed ID: 21109243
[TBL] [Abstract][Full Text] [Related]
4. The impact of trauma and post-traumatic stress disorder on the treatment response of patients with obsessive-compulsive disorder.
Shavitt RG; Valério C; Fossaluza V; da Silva EM; Cordeiro Q; Diniz JB; Belotto-Silva C; Cordioli AV; Mari J; Miguel EC
Eur Arch Psychiatry Clin Neurosci; 2010 Mar; 260(2):91-9. PubMed ID: 20077119
[TBL] [Abstract][Full Text] [Related]
5. Female hormones affect symptom severity in obsessive-compulsive disorder.
Vulink NC; Denys D; Bus L; Westenberg HG
Int Clin Psychopharmacol; 2006 May; 21(3):171-5. PubMed ID: 16528139
[TBL] [Abstract][Full Text] [Related]
6. Differences in obsessive-compulsive symptom dimensions between patients with epilepsy with obsessive-compulsive symptoms and patients with OCD.
Kilicaslan EE; Türe HS; Kasal Mİ; Çavuş NN; Akyüz DA; Akhan G; Besiroglu L
Epilepsy Behav; 2020 Jan; 102():106640. PubMed ID: 31805512
[TBL] [Abstract][Full Text] [Related]
7. Female reproductive cycle and obsessive-compulsive disorder.
Labad J; Menchón JM; Alonso P; Segalàs C; Jiménez S; Vallejo J
J Clin Psychiatry; 2005 Apr; 66(4):428-35; quiz 546. PubMed ID: 15816784
[TBL] [Abstract][Full Text] [Related]
8. Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder.
Mataix-Cols D; Rauch SL; Manzo PA; Jenike MA; Baer L
Am J Psychiatry; 1999 Sep; 156(9):1409-16. PubMed ID: 10484953
[TBL] [Abstract][Full Text] [Related]
9. Impulsivity, hostility and suicidality in patients diagnosed with obsessive compulsive disorder.
Nagy NE; El-Serafi DM; Elrassas HH; Abdeen MS; Mohamed DA
Int J Psychiatry Clin Pract; 2020 Sep; 24(3):284-292. PubMed ID: 32628055
[No Abstract] [Full Text] [Related]
10. [Psychiatric and psychological aspects of premenstrual syndrome].
Limosin F; Ades J
Encephale; 2001; 27(6):501-8. PubMed ID: 11865558
[TBL] [Abstract][Full Text] [Related]
11. Effects of tryptophan depletion on selective serotonin reuptake inhibitor-remitted patients with obsessive compulsive disorder.
Hood SD; Broyd A; Robinson H; Lee J; Hudaib AR; Hince DA
J Psychopharmacol; 2017 Dec; 31(12):1615-1623. PubMed ID: 29095069
[TBL] [Abstract][Full Text] [Related]
12. The relation of childhood trauma to suicide ideation in patients suffering from obsessive-compulsive disorder with lifetime suicide attempts.
Khosravani V; Kamali Z; Jamaati Ardakani R; Samimi Ardestani M
Psychiatry Res; 2017 Sep; 255():139-145. PubMed ID: 28549337
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological treatment strategies in obsessive compulsive disorder: A cross-sectional view in nine international OCD centers.
Van Ameringen M; Simpson W; Patterson B; Dell'Osso B; Fineberg N; Hollander E; Hranov L; Hranov G; Lochner C; Karamustafalioglu O; Marazziti D; Menchon JM; Nicolini H; Pallanti S; Stein DJ; Zohar J
J Psychopharmacol; 2014 Jun; 28(6):596-602. PubMed ID: 24429223
[TBL] [Abstract][Full Text] [Related]
14. Risperidone and haloperidol augmentation of serotonin reuptake inhibitors in refractory obsessive-compulsive disorder: a crossover study.
Li X; May RS; Tolbert LC; Jackson WT; Flournoy JM; Baxter LR
J Clin Psychiatry; 2005 Jun; 66(6):736-43. PubMed ID: 15960567
[TBL] [Abstract][Full Text] [Related]
15. Clinical features of pure obsessive-compulsive disorder.
Torres AR; Shavitt RG; Torresan RC; Ferrão YA; Miguel EC; Fontenelle LF
Compr Psychiatry; 2013 Oct; 54(7):1042-52. PubMed ID: 23746710
[TBL] [Abstract][Full Text] [Related]
16. Obsessive-compulsive symptoms among alcoholics in outpatient treatment: Prevalence, severity and correlates.
Campos LM; Yoshimi NT; Simão MO; Torresan RC; Torres AR
Psychiatry Res; 2015 Sep; 229(1-2):401-9. PubMed ID: 26150309
[TBL] [Abstract][Full Text] [Related]
17. Trajectory in obsessive-compulsive disorder comorbidities.
de Mathis MA; Diniz JB; Hounie AG; Shavitt RG; Fossaluza V; Ferrão Y; Leckman JF; de Bragança Pereira C; do Rosario MC; Miguel EC
Eur Neuropsychopharmacol; 2013 Jul; 23(7):594-601. PubMed ID: 22921470
[TBL] [Abstract][Full Text] [Related]
18. Alexithymia and perfectionism traits are associated with suicidal risk in patients with obsessive-compulsive disorder.
Kim H; Seo J; Namkoong K; Hwang EH; Sohn SY; Kim SJ; Kang JI
J Affect Disord; 2016 Mar; 192():50-5. PubMed ID: 26707347
[TBL] [Abstract][Full Text] [Related]
19. Depression and risk of suicide in patients with obsessive-compulsive disorder: A hospital-based study.
Chaudhary RK; Kumar P; Mishra BP
Ind Psychiatry J; 2016; 25(2):166-170. PubMed ID: 28659695
[TBL] [Abstract][Full Text] [Related]
20. Early maladaptive schemas and suicidal risk in an Iranian sample of patients with obsessive-compulsive disorder.
Khosravani V; Sharifi Bastan F; Samimi Ardestani M; Jamaati Ardakani R
Psychiatry Res; 2017 Sep; 255():441-448. PubMed ID: 28686949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
